This evening, American Skin Association (ASA) was awarded a $10,000 Community Grant from The Allergan Foundation at a celebratory reception held for grant recipients at the Allergan U.S. Administrative Headquarters.
|
MADISON, N.J., Sept. 25, 2019 /PRNewswire/ -- This evening, American Skin Association (ASA) was awarded a $10,000 Community Grant from The Allergan Foundation at a celebratory reception held for grant recipients at the Allergan U.S. Administrative Headquarters. The Allergan Foundation focuses its support on charitable efforts to promote access to quality healthcare and improve patient diagnosis, treatment, care, and quality of life. Since its establishment in 1998, the foundation has donated more than $84 million to charities, both domestic and abroad. "We are very proud to be recognized and awarded this community grant from The Allergan Foundation," said Howard P. Milstein, Chairman of ASA. "ASA and The Allergan Foundation share a common goal of improving patient diagnosis, treatment, and quality of life. We thank the foundation for its generosity." For thirty-two years, ASA and its affiliates have funded over $50 million in grants to support the work of more than 300 promising young scientists. Recipients have gone on to become top researchers in their fields, working on breakthrough efforts to prevent, detect and treat skin cancer and other skin diseases. The valuable research ASA funds not only address the causes and treatments of melanoma, vitiligo, psoriasis and other skin diseases, but also promises significant discoveries in the search for long sought-after cures. In the area of public education, ASA's mission is critical. In partnership with Washington University and St. Louis University, ASA provides support to SPOTS (Sun Protection Outreach Teaching by Students), an education outreach program in which medical students teach adolescents about the importance of early detection and prevention of skin cancer. Through this initiative, ASA continues to fulfill its mission of championing skin health, particularly among children. President of ASA, Dr. David Norris, said, "The Allergan Foundation's acknowledgement of ASA's efforts in providing skin health education and funding important research into skin cancer and disease is greatly appreciated. We look forward to continuing our important work with their support." ABOUT AMERICAN SKIN ASSOCIATION ABOUT THE ALLERGAN FOUNDATION ABOUT ALLERGAN PLC Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infective therapeutic categories. Allergan is an industry leader in Open Science, a model of research and development, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. With this approach, Allergan has built one of the broadest development pipelines in the pharmaceutical industry. Allergan's success is powered by our global colleagues' commitment to being Bold for Life. Together, we build bridges, power ideas, act fast and drive results for our customers and patients around the world by always doing what is right. With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives every day. For more information, visit Allergan's website at www.allergan.com.
SOURCE American Skin Association |
View original content:
